Oops! Something went wrong while submitting the form.
Services
Psychiatric medications do not act on the brain in isolation. SSRIs change gastrointestinal motility, can affect bleeding risk and can alter sleep architecture. SNRIs raise heart rate and can worsen orthostatic intolerance. Stimulant medications used for ADHD can interact with POTS, autonomic load and appetite. Mood stabilisers can change thyroid and renal function. Antihistamines used for anxiety can sedate, but they can also stabilise mast cells — sometimes usefully, sometimes more than the picture needs.
For patients in the biio. pathways, these are not edge cases. They are everyday clinical considerations. A medication chosen well can address the mental-health picture without destabilising the rest. A medication chosen by default, against a generic body assumption, can reduce anxiety while making POTS worse, or treat depression while collapsing appetite into mast-cell triggers.
Psychiatric medication management in this service is delivered by an integrative mental-health nurse practitioner with experience in complex physical health populations. The aim is medication that does what was intended, monitored against the whole clinical picture, and adjusted against what the body actually does.
This service is for adults in the biio. pathways with active mental-health medication needs — for anxiety, depression, ADHD, OCD, mood, sleep, or eating-disorder co-occurring picture — particularly where autonomic dysfunction, mast-cell activity, post-viral physiology, neurodivergence or other complex physical health is part of the picture and a generic prescribing approach has produced side-effects or limited benefit.
The first appointment reads the medication picture as it currently sits. What has been prescribed, what worked, what did not, side-effects, current physical health, autonomic and mast-cell context, prior diagnostic assessment.
A plan is built around the active mental-health question and the physical picture. Medication choices are matched to what fits — avoiding agents that will worsen the autonomic or mast-cell picture where alternatives exist, choosing dose and titration carefully in bodies that often need slower titration than standard protocols suggest.
The plan is built with the rest of the biio. team in view. Where dietetics, exercise physiology, autonomic management or other pathway work is active, medication choice and timing are built around those rather than against them. Where shared care with the patient's GP or specialist psychiatry is the structure, that is named.
Each medication trial has a review point. Symptoms tracked, side-effects tracked, autonomic markers tracked. Adjustments are made against what the body actually did, not against what the protocol predicted.
Over time, a working medication picture is established — what dose, what combination, what to do during flare, illness or stress. Clinical contact moves to background review as that picture stabilises.
Where a medication is no longer needed, or where the side-effect picture outweighs the benefit, careful tapering is part of the work. Withdrawal effects are named and managed rather than dismissed.
When the medication work is going well, the mental-health picture moves without the rest of the picture being destabilised. Anxiety eases without standing tolerance collapsing. ADHD medication produces measurable benefit without the appetite or autonomic picture being compromised beyond what the patient can hold. The patient stops cycling through medication trials that produced more side-effects than benefit.
Psychiatric medication is not the only answer to a mental-health question, and not every mental-health question is best answered with medication. Where psychology, therapy, lifestyle structure, or other parts of the plan are the better first move, that is named. Where medication is the right tool, it is delivered with the attention the broader physical picture demands.